EMA — authorised 18 January 2021
- Marketing authorisation holder: DAIICHI SANKYO EUROPE GmbH
- Status: approved
🇪🇺 Enhertu in European Union
EMA authorised Enhertu on 18 January 2021
Marketing authorisation
Enhertu in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Enhertu approved in European Union?
Yes. EMA authorised it on 18 January 2021.
Who is the marketing authorisation holder for Enhertu in European Union?
DAIICHI SANKYO EUROPE GmbH holds the EU marketing authorisation.